Drugs / PMX-30063
last change Mar 2012 re-read 2 minutes ago

PMX-30063

Developed for
methicillin-susceptible staphylococcus aureus infectious disease
Investigated by
PolyMedix, Inc.

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01211470 Oct 2010 → Dec 2011 methicillin-susceptible staphylococcus aureus infectious disease PolyMedix, Inc. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PMX-30063 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01211470